| Gilda Haydee Gomez, MD | |
|
1060 W 10th St, Rolla, MO 65401 | |
| (573) 364-9000 | |
| (573) 458-8445 |
| Full Name | Gilda Haydee Gomez |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 1060 W 10th St, Rolla, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235321753 | NPI | - | NPPES |
| Entity Name | Guam Healthcare Development Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326447939 PECOS PAC ID: 9234351776 Enrollment ID: O20150326000266 |
News Archive
Patients notched a rare win over the pharmaceutical industry Monday when the Nevada Legislature revived a bill requiring insulin makers to disclose the profits they make on the life-sustaining drug. In a handful of other states, bills addressing drug prices have stalled.
The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.
"A long-awaited state report to be released today will probably add fuel to the debate about surging health costs by portraying a mixed financial picture of Massachusetts health insurers. The state's eight health insurers finished 2008 with a total surplus of $2.5 billion, a more than four-fold increase from 1999 when the study period began, according to a 17-page executive summary of the report from the Division of Health Care Finance and Policy that was obtained by the Globe."
Contrary to what some studies may suggest, the local anesthetic drug, liposomal bupivacaine, did not reduce in-hospital opioid prescriptions or opioid-related complications in patients who received the drug during total knee replacement surgery as part of a multimodal approach to manage postsurgical pain, finds a new study published in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists.
Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gilda Haydee Gomez, MD 1060 W 10th St, Rolla, MO 65401-2905 Ph: (573) 364-9000 | Gilda Haydee Gomez, MD 1060 W 10th St, Rolla, MO 65401 Ph: (573) 364-9000 |
News Archive
Patients notched a rare win over the pharmaceutical industry Monday when the Nevada Legislature revived a bill requiring insulin makers to disclose the profits they make on the life-sustaining drug. In a handful of other states, bills addressing drug prices have stalled.
The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.
"A long-awaited state report to be released today will probably add fuel to the debate about surging health costs by portraying a mixed financial picture of Massachusetts health insurers. The state's eight health insurers finished 2008 with a total surplus of $2.5 billion, a more than four-fold increase from 1999 when the study period began, according to a 17-page executive summary of the report from the Division of Health Care Finance and Policy that was obtained by the Globe."
Contrary to what some studies may suggest, the local anesthetic drug, liposomal bupivacaine, did not reduce in-hospital opioid prescriptions or opioid-related complications in patients who received the drug during total knee replacement surgery as part of a multimodal approach to manage postsurgical pain, finds a new study published in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists.
Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.
› Verified 2 days ago
Dr. Donald L James, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-7545 Fax: 573-368-3672 | |
Bohdan A Lebedowicz, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 573-202-2440 | |
Dr. James J Spadaro Jr., M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-308-1301 Fax: 573-202-2480 | |
Dr. Hadi Bhurgri, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-458-3580 Fax: 573-202-2408 | |
John Robertson Carr, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 W 10th St, Rolla, MO 65401 Phone: 573-458-8899 | |
Dr. Dmitry Familtsev, M.D., PH.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-308-1301 Fax: 573-202-2480 | |
Dr. Thomas F Martin, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1050 W 10th St, Ste 500, Rolla, MO 65401 Phone: 573-308-1301 Fax: 573-308-1305 |